Piper Sandler Reiterates Overweight Rating for Moderna (NASDAQ:MRNA)
Moderna (NASDAQ:MRNA – Get Free Report)‘s stock had its “overweight” rating reiterated by equities research analysts at Piper Sandler in a research report issued on Friday, Benzinga reports. They currently have a $157.00 target price on the stock, down from their previous target price of $214.00. Piper Sandler’s price objective would suggest a potential upside […]
More Stories
Perpetua Resources (TSE:PPTA) Trading Up 1.7% – Here’s Why
Shares of Perpetua Resources Corp. (TSE:PPTA – Get Free Report) traded up 1.7% on Tuesday . The stock traded as...
MAG Silver (NYSEAMERICAN:MAG) Posts Quarterly Earnings Results, Beats Estimates By $0.02 EPS
MAG Silver (NYSEAMERICAN:MAG – Get Free Report) announced its quarterly earnings data on Tuesday. The company reported $0.22 EPS for...
DMG Blockchain Solutions (CVE:DMGI) Trading Down 15.9% – Here’s Why
DMG Blockchain Solutions Inc. (CVE:DMGI – Get Free Report)’s stock price traded down 15.9% on Tuesday . The company traded...
Pacific Coast Oil Trust (OTCMKTS:ROYTL) Trading Up 1.9% – Here’s Why
Pacific Coast Oil Trust (OTCMKTS:ROYTL – Get Free Report) shot up 1.9% on Tuesday . The stock traded as high...
GEA Group Aktiengesellschaft (OTCMKTS:GEAGF) Trading Down 2.3% – Here’s Why
Shares of GEA Group Aktiengesellschaft (OTCMKTS:GEAGF – Get Free Report) traded down 2.3% during trading on Tuesday . The company...
MediaCo (NASDAQ:MDIA) Stock Price Down 5% – Here’s What Happened
MediaCo Holding Inc. (NASDAQ:MDIA – Get Free Report) shares traded down 5% on Tuesday . The stock traded as low...